Literature DB >> 438117

Relationship between lysostaphin endopeptidase production and cell wall composition in Staphylococcus staphylolyticus.

J M Robinson, J K Hardman, G L Sloan.   

Abstract

Mutants of Staphylococcus staphylolyticus incapable of producing an extracellular staphylolytic glycylglycine endopeptidase were isolated and found to have cells in the population susceptible to lysis by this enzyme, as did the wild-type organism under conditions in which the endopeptidase was not produced. These results suggest that cultures of this organism normally contain a heterogeneous population of cells with regard to cell wall composition and susceptibility to the enzyme. Production of the endopeptidase appears to act as a selective pressure which removes the susceptible cells in the population as the enzyme appears in the medium. A comparison of the peptidoglycan of the wild-type organism grown under conditions in which the endopeptidase was produced with that of this organism grown under nonproducing conditions and with those of endopeptidase-less mutants showed that in the presence of the endopeptidase the cell population had peptidoglycan with shorter peptide cross bridges and a greater percentage of serine in these cross bridges than was found in cells grown in the absence of the enzyme. The inability of the endopeptidase to hydrolyze glycylserine and serylglycine peptide bonds suggests that at least part of the resistance this organism has to the endopeptidase is due to relative amounts of serine found in the peptide cross bridges of some cells in the population.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 438117      PMCID: PMC218296          DOI: 10.1128/jb.137.3.1158-1164.1979

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  20 in total

1.  LYSOSTAPHIN: A NEW BACTERIOLYTIC AGENT FOR THE STAPHYLOCOCCUS.

Authors:  C A SCHINDLER; V T SCHUHARDT
Journal:  Proc Natl Acad Sci U S A       Date:  1964-03       Impact factor: 11.205

2.  THE IN VITRO EFFECT OF LYSOSTAPHIN ON CLINICAL ISOLATES OF STAPHYLOCOCCUS AUREUS.

Authors:  C B CROPP; E F HARRISON
Journal:  Can J Microbiol       Date:  1964-12       Impact factor: 2.419

3.  PURIFICATION AND PROPERTIES OF LYSOSTAPHIN--A LYTIC AGENT FOR STAPHYLOCOCCUS AUREUS.

Authors:  C A SCHINDLER; V T SCHUHARDT
Journal:  Biochim Biophys Acta       Date:  1965-02-15

4.  A BIOCHEMICAL CHARACTERIZATION OF HISTIDINE-DEPENDENT MUTANTS OF STAPHYLOCOCCUS AUREUS.

Authors:  W E KLOOS; P A PATTEE
Journal:  J Gen Microbiol       Date:  1965-05

5.  LYSOSTAPHIN: ENZYMATIC MODE OF ACTION.

Authors:  H P BROWDER; W A ZYGMUNT; J R YOUNG; P A TAVORMINA
Journal:  Biochem Biophys Res Commun       Date:  1965-04-23       Impact factor: 3.575

6.  Development of Micrococcus lysodeikticus resistant to lysozyme.

Authors:  G LITWACK
Journal:  Nature       Date:  1958-05-10       Impact factor: 49.962

7.  Mechanisms of enzymatic bacteriaolysis. Cell walls of bacteri are solubilized by action of either specific carbohydrases or specific peptidases.

Authors:  J L Strominger; J M Ghuysen
Journal:  Science       Date:  1967-04-14       Impact factor: 47.728

8.  Chemical and biochemical studies for the differentiation of coagulase-positive staphylococci.

Authors:  K H Schleifer; F Schumacher-Perdreau; F Götz; B Popp
Journal:  Arch Microbiol       Date:  1976-11-02       Impact factor: 2.552

9.  Lysostaphin endopeptidase-catalysed transpeptidation reactions of the imino-transfer type.

Authors:  G L Sloan; E C Smith; J H Lancaster
Journal:  Biochem J       Date:  1977-10-01       Impact factor: 3.857

10.  In vitro incorporation of serine into the staphylococcal cell wall.

Authors:  E A Donegan; H G Riggs
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

View more
  25 in total

1.  Site-specific serine incorporation by Lif and Epr into positions 3 and 5 of the Staphylococcal peptidoglycan interpeptide bridge.

Authors:  K Ehlert; M Tschierske; C Mori; W Schröder; B Berger-Bächi
Journal:  J Bacteriol       Date:  2000-05       Impact factor: 3.490

2.  Inhibition of the activity of both domains of lysostaphin through peptidoglycan modification by the lysostaphin immunity protein.

Authors:  Shaw R Gargis; Harry E Heath; Paul A LeBlanc; Linda Dekker; Robin S Simmonds; Gary L Sloan
Journal:  Appl Environ Microbiol       Date:  2010-08-20       Impact factor: 4.792

3.  The molecular organization of the lysostaphin gene and its sequences repeated in tandem.

Authors:  P Heinrich; R Rosenstein; M Böhmer; P Sonner; F Götz
Journal:  Mol Gen Genet       Date:  1987-10

4.  epr, which encodes glycylglycine endopeptidase resistance, is homologous to femAB and affects serine content of peptidoglycan cross bridges in Staphylococcus capitis and Staphylococcus aureus.

Authors:  M Sugai; T Fujiwara; K Ohta; H Komatsuzawa; M Ohara; H Suginaka
Journal:  J Bacteriol       Date:  1997-07       Impact factor: 3.490

5.  Cytoplasmic control of premature activation of a secreted protease zymogen: deletion of staphostatin B (SspC) in Staphylococcus aureus 8325-4 yields a profound pleiotropic phenotype.

Authors:  Lindsey N Shaw; Ewa Golonka; Grzegorz Szmyd; Simon J Foster; James Travis; Jan Potempa
Journal:  J Bacteriol       Date:  2005-03       Impact factor: 3.490

6.  A simple and generally applicable procedure for releasing DNA from bacterial cells.

Authors:  L S Heath; G L Sloan; H E Heath
Journal:  Appl Environ Microbiol       Date:  1986-05       Impact factor: 4.792

7.  Intracellular morphological changes in Staphylococcus aureus induced by treatment with sodium hypochlorite.

Authors:  Shiori Ujimine; Shigenobu Tone; Mineki Saito; Sakuo Yamada
Journal:  Med Mol Morphol       Date:  2017-05-17       Impact factor: 2.309

8.  Expression of the lysostaphin gene of Staphylococcus simulans in a eukaryotic system.

Authors:  C M Williamson; A J Bramley; A J Lax
Journal:  Appl Environ Microbiol       Date:  1994-03       Impact factor: 4.792

9.  FmhA and FmhC of Staphylococcus aureus incorporate serine residues into peptidoglycan cross-bridges.

Authors:  Stephanie Willing; Emma Dyer; Olaf Schneewind; Dominique Missiakas
Journal:  J Biol Chem       Date:  2020-08-05       Impact factor: 5.157

10.  Cloning, sequence, and expression of the lysostaphin gene from Staphylococcus simulans.

Authors:  P A Recsei; A D Gruss; R P Novick
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.